 WES MOORE, Governor  Ch. 217  
 
– 1 – Chapter 217  
(House Bill 382 ) 
 
AN ACT concerning  
 
Pharmacy Benefits Administration – Maryland Medical Assistance Program and 
Pharmacy Benefits Managers  
Maryland Department of Health and Prescription Drug Affordability Board – 
Managed Care Organizations and Prescription Drug Claims – Study  
 
FOR the purpose of altering the reimbursement levels for drug products that the Maryland 
Medical Assistance Program is required to establish and that pharmacy benefits 
managers that contract with a pharmacy on behalf of a managed care organization 
are required to reimburse the pharmacy; altering the definition of “purchaser” for 
purposes of certain provisions of law regulating pharmacy benefits man agers to 
include certain insurers, nonprofit health services plans, and health maintenance 
organizations  requiring the Maryland Department of Health and the Prescription 
Drug Affordability Board jointly to study certain information regarding the payment 
of prescription drug claims under the Maryland Medical Assistance Program during 
certain calendar years and how to address certain inconsistencies ; and generally 
relating to pharmacy benefits administration  managed care organizations and the 
payment of presc ription drug claims . 
 
BY repealing and reenacting, with amendments,  
 Article – Health – General  
Section 15 –118(b)  
 Annotated Code of Maryland  
 (2019 Replacement Volume and 2022 Supplement)  
 
BY adding to  
 Article – Health – General  
Section 15 –118(f)  
 Annotated Code of Maryland  
 (2019 Replacement Volume and 2022 Supplement)  
 
BY repealing and reenacting, with amendments,  
 Article – Insurance  
Section 15 –1601(s)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2022 Supplement)  
 
BY adding to  
 Artic le – Insurance  
Section 15 –1632  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2022 Supplement)  
Ch. 217  2023 LAWS OF MARYLAND   
 
– 2 –  
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows : 
 
Article – Health – General  
 
15–118. 
 
 (b) (1) [Except ] SUBJECT TO PARAGRAPH (2) OF THIS SUBSECTION A ND 
EXCEPT  as provided under paragraph [(2)] (3) of this subsection, the Program shall 
establish [maximum ] reimbursement levels for the drug products for which there is a 
generic equivalent authorize d under § 12 –504 of the Health Occupations Article [, based on 
the cost of the generic product ]. 
 
  (2) EXCEPT AS PROVIDED IN  PARAGRAPH (4) OF THIS SUBSECTION , 
MINIMUM REIMBURSEMEN T LEVELS ESTABLISHED  UNDER PARAGRAPH (1) OF THIS  
SUBSECTION SHALL BE AT LEAST  EQUAL TO THE NATIONAL AVERAGE DRUG  
ACQUISITION COST OF THE GENERIC P RODUCT  PLUS THE  
FEE–FOR–SERVICE PROFESSIONAL  DISPENSING FEE DETER MINED BY THE  
DEPARTMENT IN ACCORDA NCE WITH THE MOST RE CENT IN –STATE  
COST–OF–DISPENSING SURVEY . 
 
  [(2)] (3) [If] EXCEPT AS PROVIDED IN PARAG RAPH (4) OF THIS  
SUBSECTION , IF a prescriber directs a specific brand name drug, the reimbursement level 
shall be based on the [cost] NATIONAL AVERAGE DRUG ACQUISITION COST of the 
brand name product PLUS THE FEE –FOR–SERVICE PROFESSIONAL  DISPENSING FEE  
DETERMINED BY THE DEPARTMENT IN ACCORDA NCE WITH THE MOST RE CENT  
IN–STATE COST –OF–DISPENSING SURVEY . 
 
  (4) PARAGRAPHS (2) AND (3) OF THIS SUBSECTION D O NOT APPLY TO : 
 
   (I) A PHARMACY OWNED BY , OR UNDER THE SAME CO RPORATE  
AFFILIATION , AS A PHARMACY BENEFITS MANAGER ; OR 
 
   (II) A MAIL ORDER PHARMACY .  
 
 (F) THE PROVISIONS OF § 15–1632  OF THE INSURANCE ARTICLE APPLY TO  
A MANAGED CARE ORGAN IZATION THAT USES A PHARMACY BENEFITS MA NAGER TO  
MANAGE PRESCRIPTION DRUG COVERAGE BENEFI TS ON BEHALF OF THE MANAGED  
CARE ORGANIZATION . 
 
Article – Insurance  
 
15–1601.  
 WES MOORE, Governor  Ch. 217  
 
– 3 –  
 (s) (1) “Purchaser” means a person that offers a plan or program in the State, 
including the State Employee and Retiree Health and Welfare Benefits Program,  AN 
INSURER , A NONPROFIT HEALTH S ERVICE PLAN , OR A HEALTH MAINTENA NCE 
ORGANIZATION , that:  
 
  [(1)] (I) provides prescription drug coverage or benefits in the State; and  
 
  [(2)] (II) enters into an agreement with a pharmacy benefits manager for 
the provision of pharmacy benefits management services.  
 
  (2) “PURCHASER ” DOES NOT INCLUDE A N ONPROFIT HEALTH  
MAINTENANCE ORGANIZA TION THAT : 
 
   (I) OPERATES AS A GROUP MODEL ; 
 
   (II) PROVIDES SERVICES SO LELY TO A MEMBER OR PATIENT OF  
THE NONPROFIT HEALTH  MAINTENANCE ORGANIZA TION ; AND  
 
   (III) FURNISHES SERVICES T HROUGH THE INTERNAL PHARMACY  
OPERATIONS OF THE NO NPROFIT HEALTH MAINT ENANCE ORGANIZATION .  
 
15–1632.  
 
 A PHARMACY BENEFITS MA NAGER THAT CONTRACTS  WITH A PHARMACY ON  
BEHALF OF A MANAGED CARE ORGANIZATION , AS DEFINED IN § 15–101 OF THE 
HEALTH – GENERAL ARTICLE , SHALL REIMBURSE THE PHARMACY AN AMOUNT  
THAT IS AT LEAST EQU AL TO THE NATIONAL AVERAGE DRUG ACQUISITION COST 
PLUS THE FEE –FOR–SERVICE PROFESSIONAL  DISPENSING FEE DETER MINED BY THE  
MARYLAND DEPARTMENT OF HEALTH FOR THE MARYLAND  MEDICAL ASSISTANCE  
PROGRAM IN ACCORDANCE  WITH THE MOST RECENT  IN–STATE  
COST–OF–DISPENSING SURVEY . 
 
 (a) The Maryland Department of Health and the Prescription Drug Affordability 
Board jointly shall study:  
 
  (1) (i) the total amount the managed care orga nizations in the State 
paid pharmacies for prescription drug claims in calendar years 2021 and 2022; and  
 
   (ii) what the total amount paid to pharmacies would have been, in 
calendar years 2021 and 2022, if the prescription drug claims had been reimbursed  at the 
Maryland Medical Assistance Program fee –for–service rates; and  
 
  (2) how to best address the inconsistency in the amounts studied under 
item (1) of this subsection by:  
Ch. 217  2023 LAWS OF MARYLAND   
 
– 4 –  
   (i) considering the total cost to the State; and  
 
   (ii) recommending a me thodology for determining the most accurate 
ingredient cost of a drug and an appropriate dispensing fee.  
 
 (b) On or before October 31, 2023, the Maryland Department of Health and the 
Prescription Drug Affordability Board jointly shall report its findings to the Maryland 
Medicaid Administration and, in accordance with § 2 –1257 of the State Government 
Article, the Senate Budget and Taxation Committee, the Senate Finance Committee, the 
House Appropriations Committee, and the House Health and Government Operat ions 
Committee.  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act is an emergency 
measure, is necessary for the immediate preservation of the public health or safety, has 
been passed by a yea and nay vote supported by three –fifths of all the members elected to 
each of the two Houses of the General Assembly, and shall take effect from the date it is 
enacted.  
 
Approved by the Governor, April 24, 2023.  